Literature DB >> 22926577

Quantitative proteomic analysis of human substantia nigra in Alzheimer's disease, Huntington's disease and Multiple sclerosis.

Sheng Chen1, Frances Fangjia Lu, Philip Seeman, Fang Liu.   

Abstract

The substantia nigra plays important roles in the brain function and is critical in the development of many diseases, particularly Parkinson's disease. Pathological changes of the substantia nigra have also been reported in other neurodegenerative diseases. Using a quantitative proteomic approach, we investigated protein expressions in the substantia nigra of Alzheimer's disease, Huntington's disease, and Multiple sclerosis. The expression level of one hundred and four proteins that were identified in at least three samples of each group were compared with the control group, with nineteen, twenty-two and thirteen proteins differentially expressed in Alzheimer's diseases, Huntington's disease and Multiple sclerosis respectively. The result indicates that the substantia nigra also undergoes functional adaption or damage in these diseases.

Entities:  

Mesh：

Year:  2012        PMID： 22926577     DOI： 10.1007/s11064-012-0874-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN： 0364-3190            Impact factor:   3.996


  44 in total

1.  Targeted deletion of mouse Rad1 leads to deficient cellular DNA damage responses.

Authors:  Chunbo Zhang; Yuheng Liu; Zhishang Hu; Lili An; Yikun He; Haiying Hang
Journal:  Protein Cell       Date:  2011-06-02       Impact factor: 14.870

2.  Targeting energy metabolism in Huntington's disease.

Authors:  Francis O Walker; Lynn A Raymond
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

3.  The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions.

Authors:  Kiyotoshi Kaneko; Naomi S Hachiya
Journal:  Med Hypotheses       Date:  2006-03-03       Impact factor: 1.538

4.  Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease.

Authors:  N Perez; J Sugar; S Charya; G Johnson; C Merril; L Bierer; D Perl; V Haroutunian; W Wallace
Journal:  Brain Res Mol Brain Res       Date:  1991-10

Review 5.  Heat-shock proteins as molecular chaperones.

Authors:  J Becker; E A Craig
Journal:  Eur J Biochem       Date:  1994-01-15

6.  Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease.

Authors:  Jinho Kim; Daniel J Amante; Jennifer P Moody; Christina K Edgerly; Olivia L Bordiuk; Karen Smith; Samantha A Matson; Wayne R Matson; Clemens R Scherzer; H Diana Rosas; Steven M Hersch; Robert J Ferrante
Journal:  Biochim Biophys Acta       Date:  2010-05-09

7.  The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.

Authors:  W R Gibb; C Q Mountjoy; D M Mann; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 8.  GABAergic control of substantia nigra dopaminergic neurons.

Authors:  James M Tepper; Christian R Lee
Journal:  Prog Brain Res       Date:  2007       Impact factor: 2.453

Review 9.  Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions.

Authors:  Anthony H V Schapira; C Warren Olanow
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

10.  Neuronal expression of constitutive heat shock proteins: implications for neurodegenerative diseases.

Authors:  Sheng Chen; Ian R Brown
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667
View more
  16 in total

1.  Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline.

Authors:  Lei Yu; Robert J Dawe; Patricia A Boyle; Chris Gaiteri; Jingyun Yang; Aron S Buchman; Julie A Schneider; Konstantinos Arfanakis; Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

2.  Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.

Authors:  Sonia Do Carmo; Gogce Crynen; Tiffany Paradis; Jon Reed; M Florencia Iulita; Adriana Ducatenzeiler; Fiona Crawford; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

3.  Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains.

Authors:  Tamara Ratovitski; Raghothama Chaerkady; Kai Kammers; Jacqueline C Stewart; Anialak Zavala; Olga Pletnikova; Juan C Troncoso; Dobrila D Rudnicki; Russell L Margolis; Robert N Cole; Christopher A Ross
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

4.  MPTP's pathway of toxicity indicates central role of transcription factor SP1.

Authors:  Alexandra Maertens; Thomas Luechtefeld; Andre Kleensang; Thomas Hartung
Journal:  Arch Toxicol       Date:  2015-04-08       Impact factor: 5.153

5.  Discovery of Molecular Networks of Neuroprotection Conferred by Brahmi Extract in Aβ42-Induced Toxicity Model of Drosophila melanogaster Using a Quantitative Proteomic Approach.

Authors:  Sayali Chandrashekhar Deolankar; Mohd Altaf Najar; Poornima Ramesh; Anagha Kanichery; Avinash K Kudva; Shamprasad Varija Raghu; T S Keshava Prasad
Journal:  Mol Neurobiol       Date:  2022-10-20       Impact factor: 5.682

6.  Proteomic Analysis of Dynein-Interacting Proteins in Amyotrophic Lateral Sclerosis Synaptosomes Reveals Alterations in the RNA-Binding Protein Staufen1.

Authors:  Noga Gershoni-Emek; Arnon Mazza; Michael Chein; Tal Gradus-Pery; Xin Xiang; Ka Wan Li; Roded Sharan; Eran Perlson
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

7.  Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.

Authors:  Eleanor Drummond; Shruti Nayak; Arline Faustin; Geoffrey Pires; Richard A Hickman; Manor Askenazi; Mark Cohen; Tracy Haldiman; Chae Kim; Xiaoxia Han; Yongzhao Shao; Jiri G Safar; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2017-03-04       Impact factor: 15.887

8.  The effects of endogenous non-peptide molecule isatin and hydrogen peroxide on proteomic profiling of rat brain amyloid-β binding proteins: relevance to Alzheimer's disease?

Authors:  Alexei E Medvedev; Olga A Buneeva; Arthur T Kopylov; Oksana V Gnedenko; Marina V Medvedeva; Sergey A Kozin; Alexis S Ivanov; Victor G Zgoda; Alexander A Makarov
Journal:  Int J Mol Sci       Date:  2014-12-29       Impact factor: 5.923

Review 9.  Juvenile Huntington's Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data.

Authors:  Karolina Świtońska-Kurkowska; Bart Krist; Joanna Delimata; Maciej Figiel
Journal:  Front Cell Dev Biol       Date:  2021-07-01

10.  Alzheimer's disease: are blood and brain markers related? A systematic review.

Authors:  Ali T Khan; Richard J B Dobson; Martina Sattlecker; Steven J Kiddle
Journal:  Ann Clin Transl Neurol       Date:  2016-05-11       Impact factor: 4.511
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.